The impact of peripheral arterial disease on circulating platelets
- PMID: 15115669
- DOI: 10.1016/j.thromres.2004.02.007
The impact of peripheral arterial disease on circulating platelets
Abstract
Introduction: To test the hypothesis that circulating platelets display evidence of reversible interactions with atherosclerotic lesions, platelet alpha-granule content and propensity for microaggregate formation were measured in samples from normal donors (n=65) and from patients with either peripheral arterial disease (n=47) or renovascular hypertension (n=22). To measure the effect of a defined arterial injury on platelet function, platelet samples were compared before and 30 min after elective angioplasty.
Materials and methods: P-selectin was measured after strong stimulation of ultra-dilute platelets with thrombin (10 nM). Microaggregation was measured as a platelet count deficit in citrate-anticoagulated platelet-rich plasma (PRP) relative to that predicted from the count in EDTA-anticoagulated blood.
Results: Platelet alpha-granule P-selectin was significantly lower from platelets of patients compared to normal donors. In addition, platelets from patients have a significantly greater propensity to form microaggregates in citrate anticoagulant. In contrast to atherosclerotic renovascular hypertension, platelets from patients with fibromuscular dysplasia, a distinct non-inflammatory cause of arterial stenosis, do not differ significantly from normal donors. Other than the PRP platelet count, which rose transiently following angioplasty, other platelet measures were unchanged by the injury.
Conclusions: Atherosclerotic arterial disease is associated with an increased share of platelets unable to express P-selectin and an increased fraction of platelets that microaggregate in citrate anticoagulant. These platelet alterations are not completely explained by either focal arterial injury or abnormal rheology associated with arterial stenosis but appear to be an effect of the atherosclerotic process.
Similar articles
-
Platelet characteristics associated with coronary artery disease.J Thromb Haemost. 2003 Jun;1(6):1296-303. doi: 10.1046/j.1538-7836.2003.00183.x. J Thromb Haemost. 2003. PMID: 12871333
-
Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results.Int Angiol. 1999 Jun;18(2):163-70. Int Angiol. 1999. PMID: 10424375
-
The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.Platelets. 2004 Mar;15(2):117-25. doi: 10.1080/09537105310001645960. Platelets. 2004. PMID: 15154604 Clinical Trial.
-
Platelet abnormalities in diabetes mellitus.Ann Clin Lab Sci. 1993 Jan-Feb;23(1):47-50. Ann Clin Lab Sci. 1993. PMID: 8431000 Review.
-
Serotonin, histamine and platelets in vascular disease with special reference to peripheral vascular disease.Braz J Med Biol Res. 1992;25(11):1063-76. Braz J Med Biol Res. 1992. PMID: 1342586 Review.
Cited by
-
The ARIC carotid MRI study of blood cellular markers: an inverse association of monocyte myeloperoxidase content with peripheral arterial disease.Angiology. 2011 Apr;62(3):237-44. doi: 10.1177/0003319710385336. Angiology. 2011. PMID: 21406422 Free PMC article.
-
GWAS and PheWAS of red blood cell components in a Northern Nevadan cohort.PLoS One. 2019 Jun 13;14(6):e0218078. doi: 10.1371/journal.pone.0218078. eCollection 2019. PLoS One. 2019. PMID: 31194788 Free PMC article.
-
Longitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesicles.Platelets. 2016;27(1):32-42. doi: 10.3109/09537104.2015.1023273. Epub 2015 Apr 9. Platelets. 2016. PMID: 25856160 Free PMC article. Clinical Trial.
-
Gene expression profiling of peripheral blood mononuclear cells in the setting of peripheral arterial disease.J Clin Bioinforma. 2012 Mar 12;2:6. doi: 10.1186/2043-9113-2-6. J Clin Bioinforma. 2012. PMID: 22409835 Free PMC article.
-
Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients.J Thromb Thrombolysis. 2013 Jan;35(1):100-6. doi: 10.1007/s11239-012-0787-6. J Thromb Thrombolysis. 2013. PMID: 22843195 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials